Researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy. Jessica L. Reynolds, Ph.D., associate professor of medicine in the Jacobs School, is senior author on the paper, titled "Repeated Pulmonary Dosing of β-Glucan-Chitosan-PLGA Nanoparticles Controls Mycobacterium Tuberculosis in Mice," published in Antimicrobial Agents and Chemotherapy.

From vaccines and diagnostics to emerging gene-based therapies, RNA molecules are now central to modern medicine. But as their use continues to grow, so does a fundamental challenge: producing RNA quickly, accurately and with the flexibility needed for next-generation biomedical applications.

Sulle regioni del versante adriatico le precipitazioni saranno più sporadiche, alternate a schiarite parziali, mentre in Appennino tornerà la neve.